Pharmacist Medication Insights: Tepotinib for Non-Small Cell Lung Cancer
June 21st 2021Earlier this year, the FDA granted accelerated approval to tepotinib (Tepmetko, EMD Serono Inc) for the treatment of adults with metastatic non-small cell lung cancer who are harboring MET exon 14 skipping alterations.
Watch
Jordan Tishler, MD, president of the Association of Cannabis Specialists and faculty at Harvard Medical School, discusses the importance of unbiased, knowledgeable providers being present at the site of sale of cannabis in order to provide accurate information on the appropriate use of medical cannabis for certain medical conditions.
Watch
Omega-3 Fatty Acids Could Reduce Depression Symptoms Through Anti-Inflammatory Effects
June 18th 2021The omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid were applied first in high doses to lab-grown neurons and then in patients to understand the mechanism by which they reduce inflammation and depression.
Read More
Hypertension Management in Older Adults
June 17th 2021Pharmacists play an important role in assisting with hypertension treatment by helping to modify blood pressure therapies when patients experience adverse effects or helping if a patient has difficulty remembering to take their medications.
Read More
FDA Approves Avapritinib for Advanced Systemic Mastocytosis
June 16th 2021Avapritinib is approved for adult patients with advanced systemic mastocytosis, including individuals with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.
Read More
Expert: Financial Burdens on Small Chains, Independent Pharmacies Are Creating Pharmacy Deserts
June 16th 2021Susan Lang, MA, MBA, the CEO of XIL Health and former senior executive with Express Grips, discusses what might happen to independent pharmacies if things continue as they are following the financial difficulties of the pandemic.
Watch